Naoki Fujitani Selected Research

Infections

1/2019	Prevention of respiratory syncytial virus infection with probiotic lactic acid bacterium Lactobacillus gasseri SBT2055.
9/2007	Structural transition of a 15 amino acid residue peptide induced by GM1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naoki Fujitani Research Topics

Disease

6	Neoplasms (Cancer) 12/2023 - 11/2008
3	Carcinoma (Carcinomatosis) 02/2013 - 11/2008
2	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 12/2023 - 01/2022
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2020 - 10/2019
2	Infections 01/2019 - 09/2007
2	Alzheimer Disease (Alzheimer's Disease) 01/2015 - 08/2014
2	Carcinogenesis 01/2013 - 02/2011
2	Neoplasm Metastasis (Metastasis) 01/2013 - 02/2011
2	Inflammation (Inflammations) 01/2013 - 02/2011
2	Osteoarthritis 08/2012 - 01/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023
1	Adenocarcinoma of Lung 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022
1	Disease Progression 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Respiratory Syncytial Virus Infections 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Lipoma (Lipomata) 01/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Liposarcoma 01/2019
1	Neuroblastoma 01/2015
1	Arthritis (Polyarthritis) 01/2012
1	Rheumatoid Arthritis 01/2012
1	Experimental Arthritis 01/2012

Drug/Important Bio-Agent (IBA)

5	Polysaccharides (Glycans)IBA 12/2023 - 11/2008
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
3	Peptides (Polypeptides)IBA 01/2015 - 02/2011
3	Glycoproteins (Glycoprotein)IBA 02/2013 - 11/2008
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2023 - 01/2022
2	Glutathione S-Transferase piIBA 11/2020 - 10/2019
2	CytokinesIBA 01/2019 - 01/2012
2	Amyloid (Amyloid Fibrils)IBA 01/2015 - 08/2014
2	GlycosphingolipidsIBA 02/2013 - 08/2012
1	tyrosine receptor (receptor, tyrosine)IBA 12/2023
1	ErbB Receptors (EGF Receptor)IBA 12/2023
1	Phosphotransferases (Kinase)IBA 12/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Junctional Adhesion Molecule CIBA 01/2023
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 04/2022
1	Tyrosine Kinase InhibitorsIBA 04/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	LipidsIBA 01/2022
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2022
1	Glutathione Transferase (Glutathione S-Transferase)IBA 11/2020
1	TransferasesIBA 10/2019
1	O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA 10/2019
1	Antineoplastic Agents (Antineoplastics)IBA 10/2019
1	AntioxidantsIBA 10/2019
1	EnzymesIBA 10/2019
1	Glutathione (Reduced Glutathione)IBA 10/2019
1	Leucine (L-Leucine)FDA Link 01/2019
1	ProteomeIBA 01/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	ParaffinIBA 01/2019
1	OligosaccharidesIBA 02/2013
1	GlycosaminoglycansIBA 02/2013
1	prolyl-prolyl-alanineIBA 01/2013
1	GlycopeptidesIBA 01/2013
1	EpitopesIBA 01/2013
1	alanyl-prolyl-glycineIBA 01/2013
1	histidylglycineIBA 01/2013
1	arginylprolineIBA 01/2013
1	alanylprolineIBA 01/2013
1	G(M3) GangliosideIBA 01/2012
1	InterleukinsIBA 01/2012
1	haematoside synthetaseIBA 01/2012
1	LectinsIBA 12/2011
1	MucinsIBA 02/2011
1	Uridine Diphosphate (UDP)IBA 02/2011
1	N-AcetylgalactosaminyltransferasesIBA 02/2011
1	Indicators and Reagents (Reagents)IBA 11/2008
1	Cisplatin (Platino)FDA LinkGeneric 11/2008
1	Cholera ToxinIBA 09/2007
1	peptide P3IBA 09/2007

Therapy/Procedure

3	Therapeutics 01/2023 - 10/2019
1	Drug Therapy (Chemotherapy) 12/2023
1	Oral Administration 01/2019